Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 35 Pancreatic Fistula 4 Pancreatic Ductal Adenocarcinoma 2 Jaundice, Obstructive 2 Gastroparesis 2 Bile Duct Neoplasms 2 Recurrence 1 Peritoneal Diseases 1 Periampullary Cancer 1 Pancreatitis, Chronic 1 Pancreatic Adenocarcinoma 1 Obesity 1 Non-alcoholic Fatty Liver Disease 1 Neoplasm Metastasis 1 Metabolic Syndrome 1 Locally Advanced Pancreatic Adenocarcinoma 1 Hypoxia 1 Hemorrhage 1 Gastrointestinal Stromal Tumor of Duodenum 1 Fatty Liver 1 Diabetes Mellitus 1 Cholangiocarcinoma 1 Carcinoma, Pancreatic Ductal 1 Adenocarcinoma 1

Interventions

Gemcitabine 13 Albumin-Bound Paclitaxel 8 Taxes 6 130-nm albumin-bound paclitaxel 6 Fluorouracil 5 Oxaliplatin 4 dehydroftorafur 3 Radiotherapy, Intensity-Modulated 3 Radiotherapy 3 Leucovorin 3 Irinotecan 3 Losartan 2 Cisplatin 2 tocilizumab 1 selicrelumab 1 niraparib 1 irinotecan sucrosofate 1 indusatumab 1 folfirinox 1 durvalumab 1 cobimetinib 1 atezolizumab 1 X-Rays 1 Tiragolumab 1 Surgical Procedures, Operative 1 Standard of Care 1 Specimen Handling 1 S 1 (combination) 1 Resistance Training 1 Radiotherapy, Image-Guided 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Pancreatic Adenocarcinoma × Pancreaticoduodenectomy × Clear all

NCT07547033 2026-04-23

EQUINOXE

Assistance Publique - Hôpitaux de Paris

Phase NA Not yet recruiting

Gastrointestinal

Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡